139 related articles for article (PubMed ID: 37750211)
1. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-κB p65 activation.
Cai S; Chen Y; Chen J; Wei W; Pan J; Wu H
Exp Biol Med (Maywood); 2023 Sep; 248(17):1518-1526. PubMed ID: 37750211
[TBL] [Abstract][Full Text] [Related]
2. Rubiadin-1-methyl ether from Morinda officinalis How. Inhibits osteoclastogenesis through blocking RANKL-induced NF-κB pathway.
He YQ; Zhang Q; Shen Y; Han T; Zhang QL; Zhang JH; Lin B; Song HT; Hsu HY; Qin LP; Xin HL; Zhang QY
Biochem Biophys Res Commun; 2018 Dec; 506(4):927-931. PubMed ID: 30392907
[TBL] [Abstract][Full Text] [Related]
3. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
Zhang G; Wang Y; Tang G; Ma Y
BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
Ke D; Yu Y; Li C; Han J; Xu J
Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
[TBL] [Abstract][Full Text] [Related]
6. JNK1 regulates RANKL-induced osteoclastogenesis
Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
[TBL] [Abstract][Full Text] [Related]
7. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy.
Laha D; Deb M; Das H
Autophagy; 2019 Dec; 15(12):2063-2075. PubMed ID: 30894058
[TBL] [Abstract][Full Text] [Related]
8. 1α,25-(OH)
Yu C; Zhu Y; Lv X; Wang Y
In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):878-885. PubMed ID: 34780049
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
Zhong J; Wang Z; Yuan W; Shen Y; Chen L
Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
[TBL] [Abstract][Full Text] [Related]
10. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
[TBL] [Abstract][Full Text] [Related]
11. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
[TBL] [Abstract][Full Text] [Related]
12. Anti-osteoclastogenic activity of isoliquiritigenin via inhibition of NF-κB-dependent autophagic pathway.
Liu S; Zhu L; Zhang J; Yu J; Cheng X; Peng B
Biochem Pharmacol; 2016 Apr; 106():82-93. PubMed ID: 26947453
[TBL] [Abstract][Full Text] [Related]
13. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen.
Cheng L; Zhu Y; Ke D; Xie D
Cell Prolif; 2020 Apr; 53(4):e12789. PubMed ID: 32157750
[TBL] [Abstract][Full Text] [Related]
15. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
[TBL] [Abstract][Full Text] [Related]
16. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
[TBL] [Abstract][Full Text] [Related]
17. Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways.
Xu H; Jia Y; Li J; Huang X; Jiang L; Xiang T; Xie Y; Yang X; Liu T; Xiang Z; Sheng J
Biomed Pharmacother; 2022 May; 149():112902. PubMed ID: 35364377
[TBL] [Abstract][Full Text] [Related]
18. IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling.
Chen XX; Wu HJ; Ke DS; Zhu YR
In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):300-311. PubMed ID: 37002492
[TBL] [Abstract][Full Text] [Related]
19. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.
Xiu Y; Xu H; Zhao C; Li J; Morita Y; Yao Z; Xing L; Boyce BF
J Clin Invest; 2014 Jan; 124(1):297-310. PubMed ID: 24316970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]